Teva Pharmaceutical Industries News
News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.
12 hrs ago | Hispanic Business
Dec. 05 -- Merrill Lynch has taken what it calls a "contrarian pick" for Teva Pharmaceutical Industries Ltd. , offering four reasons to buy the share in 2014.
Should America ever negotiate with terrorists?
Is America's government too big?
Israel's Teva Pharmaceutical Industries, the world's biggest producer of generic drugs, is looking to step up the pace of deal-making as it braces for a slump in sales of top-selling multiple sclerosis drug Copaxone.
Television host and film and TV producer, Jack Osbourne, is helping to raise awareness about multiple sclerosis , through a new campaign called You Don't Know Jack About MSa .
Dec. 4, 2013-- Teva Pharmaceutical Industries Ltd. today announced that 15 new projects have entered its development pipeline from its New Therapeutic Entities program.
PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits - even in bear markets.
Antares Pharma, Inc. today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday December 11, 2013 at 3:20 pm Eastern Time.
JERUSALEM & OSAKA, Japan -- -- Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva's innovative glatiramer acetate formulation for the treatment of multiple sclerosis, in Japan.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Using the GuruFocus Aggregated Portfolio Screener you can filter results to see what companies maintain the highest amount of guru ownership.
Ask big pharma executives what keeps them up at night and they'll sneer "generics."
Market Buzz Report, a leading penny stock newsletters provider, issues major news alert for Facebook Inc , Apple Inc. , Cell Therapeutics Inc , Qihoo 360 Technology Co Ltd .
Nov. 27, 2013-- Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted orphan drug exclusivity for TREANDA through October 2015 for indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
In a year when Teva Pharmaceutical Industries Ltd. lost its chief executive officer, a patent ruling on its best-selling drug and analysts became the most bearish on the stock, the Israeli drugmaker is poised for the first gain since 2009.
QRxPharma Limited announced today execution of a licensing agreement with ABIC Marketing Limited, the Israeli domestic subsidiary of Teva Pharmaceutical Industries Limited, for the commercialisation rights to immediate release MOXDUO in Israel.
Biozone Pharmaceuticals, Inc. today announced that it has agreed to terms and signed a Letter of Intent to merge with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases.